Treatment of hepatitis C after kidney transplantation with combined interferon-α and Ribovirin

唐晓鹏; 赵洪雯; 余荣杰; 吴雄飞

您当前的位置：

首页 >

文章列表页 >

Treatment of hepatitis C after kidney transplantation with combined interferon-α and Ribovirin

更新时间：2026-01-09

- Treatment of hepatitis C after kidney transplantation with combined interferon-α and Ribovirin
- Journal of Army Medical University Vol. 30, Issue 2, Pages: 117-119(2008)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：
  CLC： R512.630.5;R699.2;R978.7
- Published：2008
- 稿件说明：
移动端阅览
唐晓鹏,赵洪雯,余荣杰,吴雄飞.小剂量干扰素α联合利巴韦林治疗肾移植术后继发丙型病毒性肝炎患者的疗效观察[J].陆军军医大学学报(原第三军医大学学报),2008,30(02):117-119.

　TANG Xiao-peng,ZHAO Hong-wen,YU Rong-jie,WU Xiong-fei.Treatment of hepatitis C after kidney transplantation with combined interferon-α and Ribovirin[J].J Amry Med Univ (J Third Mil Med Univ),2008,30(02):117-119.
唐晓鹏,赵洪雯,余荣杰,吴雄飞.小剂量干扰素α联合利巴韦林治疗肾移植术后继发丙型病毒性肝炎患者的疗效观察[J].陆军军医大学学报(原第三军医大学学报),2008,30(02):117-119. DOI：

　TANG Xiao-peng,ZHAO Hong-wen,YU Rong-jie,WU Xiong-fei.Treatment of hepatitis C after kidney transplantation with combined interferon-α and Ribovirin[J].J Amry Med Univ (J Third Mil Med Univ),2008,30(02):117-119. DOI：

摘要

目的观察小剂量干扰素α联合利巴韦林对肾移植术后继发丙型病毒性肝炎患者的疗效及安全性。 方法采用小剂量干扰素α 50 μg每周1次皮下注射，同时口服利巴韦林600 mg/d治疗5例肾移植术后继发丙型病毒性肝炎患者，并每月复查血常规、肝功能、肾功能和HCV-RNA。结果在治疗12周后，有4例出现血清ALT转为正常，HCV-RNA阴性（100拷贝/ml）的早期应答，在治疗结束时这些患者出现完全应答，1例患者出现部分应答；治疗过程中，5例患者血肌酐均在正常范围内波动，并未见急性排斥反应；副反应主要为不同程度的白细胞、血红蛋白降低及低热、肌痛，但均未影响治疗。结论小剂量干扰素α联合利巴韦林治疗肾移植术后继发丙型病毒性肝炎具有较好的临床疗效，未诱发移植肾排斥反应，副反应较轻，值得临床进一步使用。

Abstract

Objective To investigate the treatment and safety of interferon α plus Ribovirin for chronic hepatitis C after kidney transplantation. Methods Five patients with chronic hepatitis C after kidney transplantation were administered with interferon α (50 μg) subcutaneously once a week

plus Ribovirin (600 mg) orally once daily. The levels of HCV-RNA

ALT and serum creatinine in patients’ serum were monitored monthly. Results Four in 5 patients presented normal ALT and negative HCV-RNA in serum 12 weeks after treatment

and obtained sustained viral response 24 weeks after interferon α plus Ribovirin therapy. During treatment

renal graft rejection did not occur. The most frequent side-effects were the decrease of leukocyte and hemoglobin

myalgia and fever

but did not influence the course of treatment. Conclusion Combination of interferon α with Ribovirin can be a valid therapeutic option in renal transplant recipients with hepatitis C

and shows no influence on the renal function.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Potential profile analysis and influencing factors of exercise fear in adult kidney transplant recipients

Inhibition of glycogen synthase kinase 3β attenuates cold ischemia/reperfusion injury in rat kidney graft

Expression and significance of protein disulfide isomerase A3 in renal allograft of rats

Expression and significance of peripheral CXCL9 and CXCR3 in rats with acute renal allografts rejection

Recombinant immunotoxin hIL-2-Luffin P1 inhibits immunological rejection in rat kidney allotransplantation

Related Author

WANG Lihua

YANG Qin

XU Xiaosong

TONG Hongyan

Zhikang YIN

Ruitu RAN

Yunlong WANG

Qilin ZHANG

Related Institution

School of Nursing， Guizhou University of Traditional Chinese Medicine

Hospital Administration Office First Affiliated Hospital， Army Medical University （Third Military Medical University）

Department of Nephrology， First Affiliated Hospital， Army Medical University （Third Military Medical University）

Department of Urology, the First Affiliated Hospital of Chongqing Medical University

⁰